Innovating Works

i-THYMUS

Financiado
The i-Thymus: wielding the potential of gene therapy, cell therapy and induced p...
The i-Thymus: wielding the potential of gene therapy, cell therapy and induced pluripotent stem cells for the regeneration of the thymus and the adaptive immune system Each year, >250 babies are born without a thymus. These babies have a life expectancy of 2-3 years. The only cure is transplantation of thymus tissue, but this has a 30% mortality rate and costs almost >€2.5M. We developed i-Thymu... ver más
31/10/2025
GENEWITY BV
4M€
Presupuesto del proyecto: 4M€
ver más
Líder del proyecto
GENEWITY BV No se ha especificado una descripción o un objeto social para esta compañía.
Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-11-17
HORIZON-EIC-2023-ACCELERATOROPEN-01: EIC Accelerator Open 2023 Scope:The EIC Accelerator Open has no predefined thematic priorities and is open to proposals in any...
Cerrada hace 1 año
0% 70% 100%